The approval will help ease supply shortages experienced by pharmacy admixture programs, according to the company.
“Having a new source for 15 percent amino acids may give healthcare providers one less thing to worry about,” said Rob Albert, senior vice president and chief marketing officer, in the release.
B. Braun is headquartered in Bethlehem, Pa.
Related Articles on B. Braun:
B. Braun to Display Advancements in Safety and Education at APIC
B. Braun Launches addEASE BC2000 Binary Connector
B. Braun Extends Supply Agreement With NxStage Medical
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
